Literatur
-
1
Berman D S, Hachamovitch R, Shaw L J. et al .
Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease.
J Nucl Med.
2006;
47
1107-1118
-
2
Isbell D C, Kramer C M.
Magnetic resonance for the assessment of myocardial viability.
Curr Opin Cardiol.
2006;
21
469-472
-
3
Jaffer F A, Weissleder R.
Seeing within: molecular imaging of the cardiovascular system.
Circ Res.
2004;
94
433-445
-
4
Behm C Z, Lindner J R.
Cellular and molecular imaging with targeted contrast ultrasound.
Ultrasound Q.
2006;
22
67-72
-
5
Falk E, Shah P K, Fuster V.
Coronary plaque disruption.
Circulation.
1995;
92
657-671
-
6
Rudd J H, Warbourton E A, Fryer T D. et al .
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.
Circulation.
2002;
105
2708-2711
-
7
Kopka K, Breyholz H J, Wagner S. et al .
Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
Nucl Med Biol.
2004;
2
257-267
-
8
Schäfers M, Riemann B, Kopka K. et al .
Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo.
Circulation.
2004;
109
2554-2559
-
9
Bremer C, Tung C H, Weissleder R.
In vivo molecular target assessment of matrix metalloproteinase inhibition.
Nat Med.
2001;
7
743-748
-
10
Schäfers M, Dutka D, Rhodes C G, Lammertsma A A, Hermansen F, Schober O, Camici P G.
Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy.
Circ Res.
1998;
82
57-62
Prof. Dr. med. Michael Schäfers
Klinik und Poliklinik für Nuklearmedizin
Universitätsklinikum Münster
Albert-Schweitzer-Str. 33
48129 Münster
Phone: 0251/83-47362
Fax: 0251/83-47363
Email: schafmi@uni-muenster.de
